Selatogrel
Sponsors
Viatris Innovation GmbH
Conditions
Acute Myocardial InfarctionChronic Coronary SyndromeHealthy SubjectsHealthy VolunteersHepatic ImpairmentStable Coronary Artery Disease
Phase 1
The Effect of Reduced Liver Function on Selatogrel Pharmacokinetics
CompletedNCT04406896
Start: 2020-07-22End: 2020-10-23Updated: 2025-07-04
A Comparative Study of Selatogrel (ACT-246475) Formulations in Healthy Subjects
CompletedNCT04557280
Start: 2020-11-06End: 2020-12-19Updated: 2025-07-03
A Trial to Compare What the Body Does to Selatogrel and the Effect of Selatogrel in Japanese and Caucasian Healthy Participants
CompletedNCT07133191
Start: 2025-10-07End: 2025-11-06Updated: 2026-07-14
A Trial to Compare What the Body Does to Selatogrel and the Effect of Selatogrel in Chinese Adults With Chronic Coronary Syndrome
RecruitingNCT07615868
Start: 2026-06-22End: 2026-10-01Target: 20Updated: 2026-07-14